(Q48756889)

15 February 2018

title

Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis (English)

1 reference

15 February 2018

0 references

2

1 reference

15 February 2018

Niels Bergsland

11

1 reference

15 February 2018

Bianca Weinstock-Guttman

12

object named as

B Weinstock-Guttman

1 reference

15 February 2018

author name string

R Zivadinov

1

1 reference

15 February 2018

S Hussein

3

1 reference

15 February 2018

E Carl

4

1 reference

15 February 2018

C Kennedy

5

1 reference

15 February 2018

M Andrews

6

1 reference

15 February 2018

D Hojnacki

7

1 reference

15 February 2018

M Heininen-Brown

8

1 reference

15 February 2018

L Willis

9

1 reference

15 February 2018

M Cherneva

10

1 reference

15 February 2018

publication date

22 December 2011

1 reference

15 February 2018

Multiple Sclerosis Journal

published in

1 reference

15 February 2018

volume

18

1 reference

15 February 2018

issue

8

1 reference

15 February 2018

page(s)

1125-1134

1 reference

15 February 2018

The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

A controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Comparative analysis of neurotrophin receptors and ligands in vertebrate neurons: tools for evolutionary stability or changes in neural circuits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511433304

21 January 2018

Identifiers

DOI

10.1177/1352458511433304

1 reference

15 February 2018

1 reference

15 February 2018